(PharmaNewsWire.Com, April 16, 2021 ) According to research report Healthcare Middleware Market is expected to reach USD 3.07 Billion by 2023 from USD 1.90 Billion in 2018, at a CAGR of 10.0%.
The availability of big data in healthcare, increasing utilization of smart devices, increasing need for data interoperability, and growing investments to overcome healthcare interoperability issues are the key drivers of the global market.
On the basis of type, the market for middleware in healthcare is segmented into communication middleware, platform middleware, integration middleware, and other middleware. The platform middleware segment is expected to command the largest share of the healthcare middleware market in 2018. Factors such as ease of deployment and use, easy interoperability, data security, portability, and cost-effectiveness are driving the growth of this segment.Based on application, the clinical application segment is expected to register the highest CAGR during the forecast period
Based on application, the healthcare middleware market is segmented into clinical, financial, and operational and administrative applications. The clinical applications segment is expected to account for the largest share of the market and is projected to register the highest CAGR during the forecast period. Middleware solutions help in auto-verification of the clinical data and reanalyzing the data for accurate results. Moreover, these tools have the ability to track laboratory performance metrics. These benefits are fueling the adoption of middleware solutions in clinical laboratories.
The market is highly fragmented with the presence of several large as well as emerging players. Prominent players in the healthcare middleware market include Corepoint Health (US), Cerner Corporation (US), Epic Systems Corporation (US), Fujitsu (Japan), IBM Corporation (US), InterSystems Corporation (US), Oracle Corporation (US), Microsoft Corporation (US), Orion Health (New Zealand), Red Hat (US), Software AG (Germany), TIBCO Software (US), Ascom (Switzerland), Informatica (US), and Zoeticx, Inc. (US).
In 2018, North America is expected to dominate the market followed by Europe. Asia is expected to grow at the highest CAGR during the forecast period. The large share of North America is attributed to factors such as the implementation of federal health mandates to encourage the adoption of HCIT solutions, increasing investment to improve data interoperability, rising pressure to curb healthcare costs and the growing adoption of smart devices.
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
